These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 9492383)

  • 1. In vivo clearance of ethoxycoumarin and its prediction from In vitro systems. Use Of drug depletion and metabolite formation methods in hepatic microsomes and isolated hepatocytes.
    Carlile DJ; Stevens AJ; Ashforth EI; Waghela D; Houston JB
    Drug Metab Dispos; 1998 Mar; 26(3):216-21. PubMed ID: 9492383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo disposition of caffeine predicted from hepatic microsomal and hepatocyte data.
    Hayes KA; Brennan B; Chenery R; Houston JB
    Drug Metab Dispos; 1995 Mar; 23(3):349-53. PubMed ID: 7628300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of drug metabolism in rat liver slices: IV. Comparison of ethoxycoumarin clearance by liver slices, isolated hepatocytes, and hepatic microsomes from rats pretreated with known modifiers of cytochrome P-450 activity.
    Carlile DJ; Hakooz N; Houston JB
    Drug Metab Dispos; 1999 Apr; 27(4):526-32. PubMed ID: 10101148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scaling factors to relate drug metabolic clearance in hepatic microsomes, isolated hepatocytes, and the intact liver: studies with induced livers involving diazepam.
    Carlile DJ; Zomorodi K; Houston JB
    Drug Metab Dispos; 1997 Aug; 25(8):903-11. PubMed ID: 9280396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolite kinetics of ondansetron in rat. Comparison of hepatic microsomes, isolated hepatocytes and liver slices, with in vivo disposition.
    Worboys PD; Brennan B; Bradbury A; Houston JB
    Xenobiotica; 1996 Sep; 26(9):897-907. PubMed ID: 8893037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sigmoidal kinetics of CYP3A substrates: an approach for scaling dextromethorphan metabolism in hepatic microsomes and isolated hepatocytes to predict in vivo clearance in rat.
    Witherow LE; Houston JB
    J Pharmacol Exp Ther; 1999 Jul; 290(1):58-65. PubMed ID: 10381760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of diazepam metabolism in rat hepatic microsomes and hepatocytes and their use in predicting in vivo hepatic clearance.
    Zomorodi K; Carlile DJ; Houston JB
    Xenobiotica; 1995 Sep; 25(9):907-16. PubMed ID: 8553684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of in vivo disposition from in vitro systems: clearance of phenytoin and tolbutamide using rat hepatic microsomal and hepatocyte data.
    Ashforth EI; Carlile DJ; Chenery R; Houston JB
    J Pharmacol Exp Ther; 1995 Aug; 274(2):761-6. PubMed ID: 7636740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verapamil hepatic clearance in four preclinical rat models: towards activity-based scaling.
    Nicolaï J; De Bruyn T; Van Veldhoven PP; Keemink J; Augustijns P; Annaert P
    Biopharm Drug Dispos; 2015 Oct; 36(7):462-80. PubMed ID: 25963583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative prediction of the in vivo inhibition of diazepam metabolism by omeprazole using rat liver microsomes and hepatocytes.
    Jones HM; Hallifax D; Houston JB
    Drug Metab Dispos; 2004 May; 32(5):572-80. PubMed ID: 15100181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 7-Ethoxycoumarin O-deethylase kinetics in isolated rat, dog and human hepatocyte suspensions.
    Bayliss MK; Bell JA; Wilson K; Park GR
    Xenobiotica; 1994 Mar; 24(3):231-41. PubMed ID: 8009886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evaluation of hepatic and extra-hepatic metabolism of coumarins using rat subcellular fractions: correlation of in vitro clearance with in vivo data.
    Behera D; Damre A; Varghese A; Addepalli V
    Drug Metabol Drug Interact; 2008; 23(3-4):329-50. PubMed ID: 19326776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of drug metabolism in rat liver slices. II. Comparison of clearance by liver slices and freshly isolated hepatocytes.
    Worboys PD; Bradbury A; Houston JB
    Drug Metab Dispos; 1996 Jun; 24(6):676-81. PubMed ID: 8781785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of species differences (rats, dogs, humans) in the in vivo metabolic clearance of YM796 by the liver from in vitro data.
    Iwatsubo T; Suzuki H; Sugiyama Y
    J Pharmacol Exp Ther; 1997 Nov; 283(2):462-9. PubMed ID: 9353358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the Predictability of Human Hepatic Clearance for Organic Anion Transporting Polypeptide Substrate Drugs Between Different In Vitro-In Vivo Extrapolation Approaches.
    Izumi S; Nozaki Y; Komori T; Takenaka O; Maeda K; Kusuhara H; Sugiyama Y
    J Pharm Sci; 2017 Sep; 106(9):2678-2687. PubMed ID: 28238896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic, intestinal, renal, and plasma hydrolysis of prodrugs in human, cynomolgus monkey, dog, and rat: implications for in vitro-in vivo extrapolation of clearance of prodrugs.
    Nishimuta H; Houston JB; Galetin A
    Drug Metab Dispos; 2014 Sep; 42(9):1522-31. PubMed ID: 24994071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of in vivo carbamazepine 10,11-epoxidation from in vitro metabolic studies with human liver microsomes: importance of its sigmoidal kinetics.
    Sakamoto M; Itoh T; Fujiwara R
    Biol Pharm Bull; 2013; 36(12):1959-63. PubMed ID: 24292054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substrate depletion approach for determining in vitro metabolic clearance: time dependencies in hepatocyte and microsomal incubations.
    Jones HM; Houston JB
    Drug Metab Dispos; 2004 Sep; 32(9):973-82. PubMed ID: 15319339
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Morita K; Kato M; Kudo T; Ito K
    Xenobiotica; 2020 Sep; 50(9):1064-1075. PubMed ID: 32125203
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of HμREL Human Coculture System for Prediction of Intrinsic Clearance and Metabolite Formation for Slowly Metabolized Compounds.
    Hultman Ia; Vedin C; Abrahamsson A; Winiwarter S; Darnell M
    Mol Pharm; 2016 Aug; 13(8):2796-807. PubMed ID: 27377099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.